MediVet Biologics Completes Initial Cancer Trial Utilizing...

MediVet Biologics, a leader in Veterinary Regenerative Medicine and Biologics Solutions, announced the closing of its Canine Autologous Cancer Vaccine Trial.(PRWeb January 11, 2016)Read the full story at http://www.prweb.com/releases/2016/01/prweb13159020.htm

Source: PRWeb: Medical Pharmaceuticals - January 12, 2016 Category: Pharmaceuticals Source Type: news